11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional … - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …
the ADA's current clinical practice recommendations and is intended to provide the …
Sodium–glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus
AJ Scheen - Nature reviews endocrinology, 2020 - nature.com
The management of type 2 diabetes mellitus (T2DM) is becoming increasingly complex.
Sodium–glucose cotransporter type 2 inhibitors (SGLT2is) are the newest antidiabetic …
Sodium–glucose cotransporter type 2 inhibitors (SGLT2is) are the newest antidiabetic …
The tubular hypothesis of nephron filtration and diabetic kidney disease
V Vallon, SC Thomson - Nature Reviews Nephrology, 2020 - nature.com
Kidney size and glomerular filtration rate (GFR) often increase with the onset of diabetes,
and elevated GFR is a risk factor for the development of diabetic kidney disease …
and elevated GFR is a risk factor for the development of diabetic kidney disease …
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
Background Cardiovascular and kidney outcome trials have shown that sodium-glucose co-
transporter-2 (SGLT2) inhibitors slow progression of chronic kidney disease in patients with …
transporter-2 (SGLT2) inhibitors slow progression of chronic kidney disease in patients with …
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021
American Diabetes Association - Diabetes care, 2021 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …
the ADA's current clinical practice recommendations and is intended to provide the …
SGLT2 inhibitors: a review of their antidiabetic and cardioprotective effects
Type 2 diabetes mellitus is a chronic metabolic disease associated with high cardiovascular
(CV) risk. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are the latest class of …
(CV) risk. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are the latest class of …
The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
MC Thomas, DZI Cherney - Diabetologia, 2018 - Springer
Inhibition of the sodium–glucose cotransporter (SGLT) 2 in the proximal tubule of the kidney
has a broad range of effects on renal function and plasma volume homeostasis, as well as …
has a broad range of effects on renal function and plasma volume homeostasis, as well as …
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2024
Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
[HTML][HTML] Characterization and implications of the initial estimated glomerular filtration rate 'dip'upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the …
BJ Kraus, MR Weir, GL Bakris, M Mattheus… - Kidney International, 2021 - Elsevier
Abstract Treatment with sodium-glucose co-transporter-2 inhibitors induces an initial 3–5
ml/min/1.73 m 2 decline in estimated glomerular filtration rate (eGFR). Although considered …
ml/min/1.73 m 2 decline in estimated glomerular filtration rate (eGFR). Although considered …